Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.
Alatrash G, de Lima M, Hamerschlak N, Pelosini M, Wang X, Xiao L, Kerbauy F, Chiattone A, Rondon G, Qazilbash MH, Giralt SA, de Padua Silva L, Hosing C, Kebriaei P, Zhang W, Nieto Y, Saliba RM, Champlin RE, Andersson BS. Alatrash G, et al. Among authors: nieto y. Biol Blood Marrow Transplant. 2011 Oct;17(10):1490-6. doi: 10.1016/j.bbmt.2011.02.007. Epub 2011 Feb 18. Biol Blood Marrow Transplant. 2011. PMID: 21338705 Free PMC article. Clinical Trial.
Status of high-dose chemotherapy for breast cancer: a review.
Nieto Y, Champlin RE, Wingard JR, Vredenburgh JF, Elias AD, Richardson P, Glaspy J, Jones RB, Stiff PJ, Bearman SI, Cagnoni PJ, McSweeney PA, LeMaistre CF, Pecora AL, Shpall EF. Nieto Y, et al. Biol Blood Marrow Transplant. 2000;6(5):476-95. doi: 10.1016/s1083-8791(00)70019-x. Biol Blood Marrow Transplant. 2000. PMID: 11063377 Free article. Review.
Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory malignancies.
Nieto Y, Shpall EJ, Bearman SI, McSweeney PA, Cagnoni PJ, Matthes S, Gustafson D, Long M, Barón AE, Jones RB. Nieto Y, et al. Biol Blood Marrow Transplant. 2005 Apr;11(4):297-306. doi: 10.1016/j.bbmt.2005.01.002. Biol Blood Marrow Transplant. 2005. PMID: 15812395 Free article. Clinical Trial.
Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.
Nieto Y, Patton N, Hawkins T, Spearing R, Bearman SI, Jones RB, Shpall EJ, Rabinovitch R, Zeng C, Barón A, McSweeney PA. Nieto Y, et al. Biol Blood Marrow Transplant. 2006 Feb;12(2):217-25. doi: 10.1016/j.bbmt.2005.10.012. Biol Blood Marrow Transplant. 2006. PMID: 16443519 Free article. Clinical Trial.
Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.
Nieto Y, Aldaz A, Rifón J, Pérez-Calvo J, Zafra A, Zufia L, Viúdez A, Viteri S, Aramendía JM, Aristu J, Centeno C, Moreno M, Sayar O, Hernández M. Nieto Y, et al. Biol Blood Marrow Transplant. 2007 Nov;13(11):1324-37. doi: 10.1016/j.bbmt.2007.07.008. Epub 2007 Sep 7. Biol Blood Marrow Transplant. 2007. PMID: 17950919 Free article. Clinical Trial.
302 results